Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Gynecologic Oncology|December 13, 2023
PREDICT-GTN 2: Two-factor streamlined models match FIGO performance in gestational trophoblastic neoplasiaVictoria L Parker, Matthew C Winter, John A Tidy, et al.European Journal of Cancer (Oxford, England : 1990)|August 9, 2020
Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysisAlice Bergamini, Naveed Sarwar, Gabriella Ferrandina, et al.European Urology Open Science|January 3, 2022
A Systematic Review of Patients' Values, Preferences, and Expectations for the Treatment of Metastatic Prostate CancerMartin J Connor, Mesfin G Genie, David Burns, et al.European Urology|May 27, 2011
The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancerThomas Powles, Christian Blank, Simon Chowdhury, et al.Oncogene|July 16, 2002
Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antiseraDongsheng Chen, Elinor Washbrook, Naveed Sarwar, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 6, 2023
Fertility outcomes following surgery and multiagent chemotherapy in malignant ovarian germ cell tumor survivors: a survey studyAlice Bergamini, Ramya Ramaswami, Fieke Froeling, et al.NPJ Genomic Medicine|April 9, 2022
Sensitive screening of single nucleotide polymorphisms in cell free DNA for diagnosis of gestational tumoursGeoffrey J Maher, Rosemary A Fisher, Baljeet Kaur, et al.European Journal of Cancer (Oxford, England : 1990)|June 9, 2014
A phase Ib study investigating the combination of everolimus and dovitinib in vascular endothelial growth factor refractory clear cell renal cancerThomas Powles, Shah-Jalal Sarker Foreshew, Jonathan Shamash, et al.International Journal of Cancer|November 8, 2022
PREDICT-GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?Victoria L Parker, Matthew C Winter, John A Tidy, et al.British Journal of Cancer|February 23, 2019
Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumoursFieke E M Froeling, Ramya Ramaswami, Panagiotis Papanastasopoulos, et al.Pageof 5